RBCK1 Gene Polyglucosan Body Myopathy Type 1 with or without Immunodeficiency is a rare genetic disorder characterized by the accumulation of polyglucosan bodies in muscle and nerve cells, leading to muscle weakness and, in some cases, immunodeficiency. The condition is caused by mutations in the RBCK1 gene, which plays a crucial role in the immune response and muscle function.
DNA Labs UAE offers a genetic test to diagnose this condition by analyzing the RBCK1 gene for mutations. This test is crucial for individuals showing symptoms of the disorder or those with a family history of the condition, as it can confirm the diagnosis and help in managing the symptoms effectively.
The cost of the RBCK1 Gene Polyglucosan Body Myopathy Type 1 with or Without Immunodeficiency Genetic Test at DNA Labs UAE is 4400 AED. This test is performed with a high level of accuracy, utilizing advanced genetic sequencing technologies to detect mutations in the RBCK1 gene. The result from this test can provide essential information for the patient's healthcare provider to devise an appropriate treatment and management plan, potentially improving the quality of life for affected individuals.
The NR2E1 gene plays a significant role in brain development, and mutations in this gene are linked to a rare neurological condition known as polymicrogyria, specifically affecting the occipital lobes bilaterally. Polymicrogyria is characterized by an excessive number of small and malformed cerebral cortical folds, which can lead to a range of neurological issues, including developmental delays, seizures, and difficulties with coordination and speech.
To diagnose this genetic condition, DNA Labs UAE offers a specialized genetic test targeting the NR2E1 gene. This test is designed to identify mutations that may be responsible for bilateral occipital polymicrogyria, providing crucial information for accurate diagnosis and potential management strategies for affected individuals. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately detect and interpret mutations in the NR2E1 gene. Conducting this test can be a critical step for families seeking answers to developmental and neurological challenges faced by their loved ones, enabling access to targeted support and interventions.
The GAA Gene Pompe Disease Genetic Test is a specialized diagnostic procedure designed to identify mutations in the GAA gene, which are responsible for Pompe Disease. This condition, also known as Glycogen Storage Disease Type II, is a rare and often fatal genetic disorder that impairs the body's ability to break down glycogen due to the deficiency of the lysosomal acid alpha-glucosidase enzyme. The accumulation of glycogen in cells, especially muscle cells, leads to progressive muscle weakness, heart and respiratory problems, and, in severe cases, premature death.
The test involves analyzing the patient's DNA to detect mutations in the GAA gene, offering crucial information for the diagnosis, management, and treatment planning of Pompe Disease. It is particularly important for families with a history of the condition, individuals showing symptoms of muscle weakness and respiratory difficulties, and couples considering pregnancy who wish to understand their genetic risks.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the GAA Gene Pompe Disease Genetic Test ensures accuracy and confidentiality, providing patients and healthcare providers with critical insights into this genetic disorder. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology required to accurately identify the GAA gene mutations. This investment can be invaluable for affected families, offering a pathway to early intervention and tailored treatment strategies that can significantly improve quality of life and outcomes for individuals with Pompe Disease.
The VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test is a specialized diagnostic assessment conducted to identify mutations in the VRK1 gene, which are linked to Pontocerebellar Hypoplasia Type 1A (PCH1A). PCH1A is a rare genetic disorder characterized by the underdevelopment of the cerebellum and brainstem, leading to severe neurological impairments. This condition manifests early in life, affecting motor functions, cognitive development, and in many cases, leading to early mortality.
The test is crucial for families with a history of PCH1A, as it provides definitive genetic evidence of the disorder, enabling accurate diagnosis, management, and genetic counseling. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for mutations in the VRK1 gene.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test ensures high precision and reliability. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. This test is a vital tool for healthcare providers and families affected by PCH1A, offering insights into the condition and aiding in the development of personalized care plans.
The "EXOSC3 Gene Pontocerebellar Hypoplasia Type 1B Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the EXOSC3 gene, which are linked to Pontocerebellar Hypoplasia Type 1B (PCH1B). This rare genetic disorder affects the development of the brain, particularly the pons and cerebellum, leading to significant neurological impairments. The test is crucial for early diagnosis, enabling appropriate management and care planning for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the EXOSC3 gene to detect any abnormalities. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations associated with this condition. Through this test, families can gain essential insights into the genetic underpinnings of PCH1B, facilitating informed decisions about treatment options and genetic counseling.
The TSEN54 gene is associated with a rare genetic disorder known as Pontocerebellar Hypoplasia Type 2A (PCH2A), which affects the development and function of the brain, particularly the pons and cerebellum. This condition is characterized by significant developmental delay, movement problems, and intellectual disability, with symptoms appearing in infancy.
A genetic test specifically designed to identify mutations in the TSEN54 gene can confirm a diagnosis of PCH2A. This test is crucial for families seeking answers about their child's developmental issues, as it can provide definitive evidence of the condition, allowing for better-informed decisions regarding care and management.
In the UAE, this specialized genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the TSEN54 gene test for Pontocerebellar Hypoplasia Type 2A is 4400 AED. Opting for this test at DNA Labs UAE ensures accuracy and reliability, as the laboratory is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics. This test is an essential tool for families and healthcare providers in the management and understanding of PCH2A, enabling a targeted approach to treatment and support for affected individuals.
The TSEN2 gene pontocerebellar hypoplasia type 2B genetic test is a specialized diagnostic tool aimed at detecting mutations in the TSEN2 gene, which are linked to pontocerebellar hypoplasia type 2B (PCH2B). PCH2B is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two crucial parts of the brain responsible for movement coordination, balance, and various bodily functions. This condition manifests early in life and is associated with severe neurological impairments.
Conducted at DNA Labs UAE, the test is designed for individuals who are suspected to have PCH2B based on clinical symptoms or for those with a family history of the condition seeking genetic counseling. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the presence of specific mutations in the TSEN2 gene that are indicative of PCH2B.
The cost of the TSEN2 gene pontocerebellar hypoplasia type 2B genetic test at DNA Labs UAE is 4400 AED. This price may cover the test itself, the expertise of the genetic counselors, and the detailed report provided after analysis. The test's results can offer crucial information for affected families, including the confirmation of a diagnosis, understanding the risk of passing the condition to future generations, and guiding treatment and management decisions. It's an important step in the journey towards personalized medicine and offers hope for better outcomes through targeted interventions.
The TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test is a specialized diagnostic tool designed to identify mutations in the TSEN34 gene, which are linked to Pontocerebellar Hypoplasia Type 2C (PCH2C). PCH2C is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two critical regions of the brain responsible for controlling movement and coordination. This condition manifests early in life and can lead to significant neurological impairments, including difficulties with movement, speech, and in some cases, intellectual disabilities.
The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. Utilizing advanced genomic sequencing technologies, DNA Labs UAE offers this test at a cost of 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in their state-of-the-art laboratory facilities. The aim is to detect any mutations in the TSEN34 gene that may indicate the presence of PCH2C, thereby providing crucial information for diagnosis, management, and familial genetic counseling.
Given the complexity and rarity of Pontocerebellar Hypoplasia Type 2C, the TSEN34 Gene Test is an invaluable resource for affected families seeking answers and medical professionals aiming to tailor care plans to the specific needs of their patients.
The SEPSECS gene pontocerebellar hypoplasia type 2D genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SEPSECS gene, which are associated with pontocerebellar hypoplasia type 2D (PCH2D). PCH2D is a rare genetic disorder characterized by the underdevelopment of the cerebellum and pons, two critical regions of the brain involved in controlling movement and coordination. This condition often presents significant developmental challenges and neurological symptoms from infancy.
DNA Labs UAE offers this genetic test as a crucial tool for healthcare providers and families seeking answers about this specific form of pontocerebellar hypoplasia. By analyzing an individual's DNA, the test can confirm a diagnosis of PCH2D, thus enabling appropriate care and management strategies to be implemented. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SEPSECS gene.
Undergoing this test at DNA Labs UAE ensures access to state-of-the-art genetic testing services, provided by a team of experts in the field of genetic diagnostics. The results from this test can be pivotal for families in understanding the condition, planning for the future, and connecting with support and resources tailored to their needs.
The VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the VPS53 gene, which are associated with Pontocerebellar Hypoplasia Type 2E (PCH2E). PCH2E is a rare genetic disorder characterized by the underdevelopment of the cerebellum and brainstem, leading to severe neurological impairments. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is crucial for early diagnosis, which can help in the management of symptoms and in providing supportive care for affected individuals. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the VPS53 gene.
At DNA Labs UAE, the cost of the VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test is 4400 AED. Given the complexity of the test and the expertise required to interpret the results, this price reflects the comprehensive service provided by the laboratory, including pre-test counseling, the testing process itself, and post-test interpretation and counseling. This test is an invaluable resource for families with a history of PCH2E, offering them crucial information for understanding their genetic health and making informed decisions.
